Literature DB >> 32532936

COVID-19 and gastrointestinal injury: a brief systematic review and data from Bulgaria.

Valeri Velev1, Metodi Popov1, Petar Velikov1, Maria Dinkova1, Viktoria Ilieva2, Gabriela Gospodinova1, Tatiana Tcherveniakova1, Maria Pavlova3.   

Abstract

In December 2019, a new Coronavirus (SARS-CoV-2) emerged in China, causing the pandemic disease COVID-19. The clinical presentation is variable, but the predominant symptoms are those of the upper respiratory tract. AIM: The aim of the current study is to describe the incidence and type of the gastrointestinal injury (GI) in COVID-19, as well as their prognostic value.
MATERIALS AND METHODS: We conducted a coincidental search on this topic in PubMed, Web of Science and EMBASE. We also followed a group of 31 Bulgarian COVID-19 patients throughout the course of their disease and analyzed their symptoms (catarrhal and other) and outcome.
RESULTS: The publications concerning our survey followed a total of 1509 COVID-19 patients. In the Bulgarian cohort, only 14 from the 31 patients were laboratory-confirmed COVID-19 cases. Approximately 1/3 of the infected individuals presented with GI. In some patients this was the first, or only, symptom of the disease. It was also indicative of a more severe disease course.
CONCLUSION: GI may be an important symptom and prognostic factor in COVID-19. Therefore, patients with acute gastrointestinal symptoms must be actively tested for SARS-CoV-2.

Entities:  

Mesh:

Year:  2020        PMID: 32532936

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  1 in total

1.  Gastrointestinal manifestations in American minority population with COVID-19.

Authors:  Aleksandr Kalabin; Vishnu Raj Kumar Mani; Sebastian Cristobal Valdivieso; Brian Donaldson
Journal:  Infez Med       Date:  2021-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.